Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: An Australian and New Zealand Gynaecological Oncology Group study

P. Harnett^*, M. Buck, P. Beale, A. Goldrick, S. Allan, B. Fitzharris, P. De Souza, M. Links, G. Kalimi, T. Davies, R. Stuart-Harris

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review